Conditioned immunosuppression makes subtherapeutic cyclosporin effective via splenic innervation

American Journal of Physiology - Regulatory Integrative and Comparative Physiology

Volumn 276, Issue 6 45-6, 1999, Pages

  Exton, Michael S ^a,d   Schult, Marc ^b   Donath, Stefan ^b   Strubel, Tim ^b   Bode, Ulrike ^b   Del Rey, Adriana ^c   Westermann, Jürgen ^b   Schedlowski, Manfred ^a  

^a UNIVERSITY OF DUISBURG ESSEN   (Germany)

^b HANNOVER MEDICAL SCHOOL   (Germany)

^c PHILIPPS UNIVERSITY MARBURG   (Germany)

^d UNIVERSITY HOSPITAL ESSEN   (Germany)

Author keywords

Classical conditioning; Cytokine; Graft survival; Heart transplantation; Interferon

Indexed keywords

CD4 ANTIGEN; CYCLOSPORIN A; GAMMA INTERFERON; INTERLEUKIN 2; SACCHARIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUTONOMIC DENERVATION; CELL PROLIFERATION; CONDITIONING; CONTROLLED STUDY; GRAFT REJECTION; GRAFT SURVIVAL; HEART TRANSPLANTATION; IMMUNOSUPPRESSIVE TREATMENT; INNERVATION; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; MEMORY CELL; NONHUMAN; PRIORITY JOURNAL; RAT; SPLEEN; SPLEEN CELL; STIMULUS RESPONSE; SURVIVAL; SYMPATHETIC INNERVATION; T LYMPHOCYTE SUBPOPULATION;

EID: 0033001520     PISSN: 03636119     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpregu.1999.276.6.r1710     Document Type: Article

References (29)

1. Ader, R., and N. Cohen. Behaviorally conditioned immunosuppression and murine systemic lupus erythematosus. Science 215: 1534-1536, 1982.
2. Ader, R., and N. Cohen. Psychoneuroimmunology: conditioning and stress. Annu. Rev. Psychol. 44: 53-85, 1993.
3. Benschop, R. J., M. Rodriguez-Feuerhahn, and M. Schedlowski. Catecholamine-induced leukocytosis: early observations, current research, and future directions. Brain Behav. Immun. 10: 77-91, 1996.
4. Bolling, S. F., H. Lin, R.-Q. Wie, P. Linsley, and L. A. Turka. The effect of combination cyclosporine and CTLA-Ig therapy on cardiac allograft survival. J. Surg. Res. 57: 60-64, 1994.
5. Briggs, W. A., Z. H. Gao, L. F. Gimenez, P. J. Scheel, M. J. Choi, and J. F. Burdick. Lymphocyte responsiveness to glucocorticoids, cyclosporine, or both. J. Clin. Pharmacol. 36: 707-714, 1996.
6. Cosenza, C. A., D. V. Cramer, G. Eiras-Hreha, E. Cajulis, H. K. Wang, and L. Makowka. The synergism of brequinar sodium and cyclosporine used in combination to prevent cardiac allograft rejection in the rat. Transplantation 56: 667-672, 1993.
7. Del Rey, A., I. Klusman, and H. O. Besedovsky. Cytokines mediate protective stimulation of glucocorticoid output during autoimmunity: involvement of IL-1. Am. J. Physiol. 275 (Regulatory Integrative Comp. Physiol. 44): R1146-R1151, 1998.
8. Exton, M. S., S. von Hörsten, M. Schult, J. Vöge, T. Strubel, S. Donath, C. Steinmüller, H. Seeliger, E. Nagel, J. Westermann, and M. Schedlowski. Behaviorally conditioned immunosuppression using cyclosporin A: central nervous system reduces IL-2 production via splenic innervation. J. Neuroimmunol. 88: 182-191, 1998.
9. Faulds, D., K. L. Goa, and P. Benfield. Cyclosporin: a review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in immunoregulatory disorders. Drugs 45: 953-1040, 1993.
10. Felten, D. L., S. Y. Felten, D. L. Bellinger, S. L. Carlson, K. D. Ackerman, K. S. Madden, J. A, Olschowka, and S. Livnat. Noradrenergic sympathetic neural interactions with the immune system: structure and function. Immunol. Rev. 100: 225-260, 1987.
11. Fuchs, B. A., K. S. Campbell, and A. E. Munson. Norepinephrine and serotonin content of the murine spleen: its relationship to lymphocyte β-adrenergic receptor density and the humoral immune response in vivo and in vitro. Cell. Immunol. 117: 339-351, 1988.
12. Grochowicz, P. M, M. Schedlowski, A. J. Husband, M. G. King, A. D. Hibberd, and K. M. Bowen. Behavioral conditioning prolongs heart allograft survival in rats. Brain Behav. Immun. 5: 349-356, 1991.
13. Hall, B. M. Cells mediating graft rejection. Transplantation 51: 1141-1151, 1991.
14. +) cells. J. Neuroimmunol. 74: 159-164, 1997.
15. Kruszewska, B., S. Y. Felten, and J. A. Moynihan. Alterations in cytokine and antibody production following chemical sympathectomy in two strains of mice. J. Immunol. 155: 4613-4620, 1995.
16. Luecken, L. J., and D. T. Lysle. Evidence for the involvement of β-adrenergic receptors in conditioned immunomodulation. J. Neuroimmunol. 38: 209-220, 1992.
17. Murphy, E., K. Shibuya, N. Hosken, P. Openshaw, V. Maino, K. Davis, K. Murphy, K., and A. O'Garra. Reversibility of T helper 1 and 2 populations is lost after long-term stimulation. J. Exp. Med. 183: 901-913, 1996.
18. Ono, K., and E. S. Lindsey. Improved technique of heart transplantation in rats. J. Thorac. Cardiovasc. Surg. 57: 225-229, 1969.
19. Perez, L., and D. T. Lysle. Conditioned immunomodulation: investigations of the role of endogenous activity at μ, κ, and δ opioid receptor subtypes. J. Neuroimmunol. 79: 101-112, 1997.
20. Rogausch, H., A. del Rey, A. Kabiersch, W. Reschke, J. Örtel, and H. Besedovsky. Endotoxin impedes vasoconstriction in the spleen: role of endogenous interleukin-1 and sympathetic innervation. Am. J. Physiol. 272 (Regulatory Integrative Comp. Physiol. 41): R2048-R2054, 1997.
21. 2-adrenergic receptor by Th1 and Th2 clones. J. Immunol. 158: 4200-4210, 1997.
22. 2-adrenergic mechanisms. J. Immunol. 156: 93-99, 1996.
23. Schumann, G., D. Petersen, P. F. Hoyer, and K. Wonigeit. Monitoring cyclosporin A (Ciclosporin, INN) concentrations in whole blood: evaluation of the EMIT assay in comparison with HPLC and RIA. Eur. J. Clin. Chem. Clin. Biochem. 31: 381-388, 1993.
24. Stepkowski, S. M., L. Tian, K. L. Napoli, R. Ghobrial, M. E. Wang, T. C. Chou, and B. D. Kahan. Synergistic mechanisms by which sirolimus and cyclosporin inhibit rat heart and kidney allograft rejection. Clin. Exp. Immunol. 108: 63-68, 1997.
25. Straub, R. H., J. Westermann, J. Schölmerich, and W. Falk. Communication between CNS and immune system in lymphoid organs: synaptic dialogue with macrophages and lymphocytes. Immunol. Today 19: 409-413, 1998.
26. Vathsala, A., T. C. Chou, and B. D. Kahan. Analysis of the interactions of immunosuppressive drugs with cyclosporine in inhibiting DNA proliferation. Transplantation 49: 463-472, 1990.
27. von Hörsten, S., M. S. Exton, M. Schult, E. Nagel, M. Stalp, G. Schweitzer, J. Vöge, A. del Rey, M. Schedlowski, and J. Westermann. Behaviorally conditioned effects of cyclosporin A on the immune system of rats: specific alterations of blood leukocyte numbers and decrease of granulocyte function. J. Neuroimmunol. 85: 193-201, 1998.
28. Westermann, J., S. Persin, J. Matyas, P. van der Meide, and R. Pabst. Migration of so-called naive and memory T lymphocytes from blood to lymph in the rat. J. Immunol. 152: 1744-1750, 1994.
29. Wilckens, T., and R. De Rijk. Glucocorticoids and immune function: unknown dimensions and new frontiers. Immunol. Today 18: 418-424, 1997.